These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8849913)
21. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740 [TBL] [Abstract][Full Text] [Related]
22. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic/therapeutic effects and induction of reversal reactions with thymus transplantation in Mycobacterium leprae-infected nude mice. Kohsaka K; Miyata Y; Mori T; Ito T Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):284-8. PubMed ID: 3522771 [TBL] [Abstract][Full Text] [Related]
24. Factors influencing the in vitro growth of Mycobacterium leprae: effect of inoculum. Dhople AM Microbios; 1998; 94(378):103-12. PubMed ID: 9785489 [TBL] [Abstract][Full Text] [Related]
25. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031 [TBL] [Abstract][Full Text] [Related]
26. In vitro studies on extracellular matrix production by M.leprae infected murine neurofibroblasts. Singh N; Birdi TJ; Chandrashekar S; Antia NH Lepr Rev; 1998 Sep; 69(3):246-56. PubMed ID: 9805880 [TBL] [Abstract][Full Text] [Related]
27. Challenges presented by nerve damage in leprosy. Harboe M; Aseffa A; Leekassa R Lepr Rev; 2005 Mar; 76(1):5-13. PubMed ID: 15881032 [TBL] [Abstract][Full Text] [Related]
28. Differences in M. leprae-induced nerve damage in Swiss white and C57BL/6 mice. Birdi TJ; Shetty VP; Antia NH Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):573-4. PubMed ID: 8642224 [No Abstract] [Full Text] [Related]
29. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease. de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596 [TBL] [Abstract][Full Text] [Related]
30. Relationship between T-cell population in neonatally thymectomized Lewis rats and susceptibility to infection with mycobacterium leprae. Fieldsteel AH; Sato N; Colston MJ Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):317-23. PubMed ID: 7033149 [TBL] [Abstract][Full Text] [Related]
31. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases. Vardhini D; Suneetha S; Ahmed N; Joshi DS; Karuna S; Magee X; Vijayalakshmi DS; Sridhar V; Karunakar KV; Archelos JJ; Suneetha LM Infect Genet Evol; 2004 Mar; 4(1):21-8. PubMed ID: 15019586 [TBL] [Abstract][Full Text] [Related]
32. Ultrastructural features of macrophages of armadillos infected with actively multiplying Mycobacterium leprae. Fukunishi Y; Meyers WM; Walsh GP; Johnson FB; Binford CH; Okada S; Nishiura M Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):198-202. PubMed ID: 6373628 [TBL] [Abstract][Full Text] [Related]
33. Serum demyelinating factors and adjuvant-like activity of Mycobacterium leprae: possible causes of early nerve damage in leprosy. Shetty VP; Mistry NF; Antia NH Lepr Rev; 1985 Sep; 56(3):221-7. PubMed ID: 3903408 [No Abstract] [Full Text] [Related]
34. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Chattree V; Khanna N; Rao DN Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060 [TBL] [Abstract][Full Text] [Related]
35. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy. Adams LB; Scollard DM; Ray NA; Cooper AM; Frank AA; Orme IM; Krahenbuhl JL J Infect Dis; 2002 Feb; 185 Suppl 1():S1-8. PubMed ID: 11865434 [TBL] [Abstract][Full Text] [Related]
36. Mycobacterium leprae-induced demyelination: a model for early nerve degeneration. Rambukkana A Curr Opin Immunol; 2004 Aug; 16(4):511-8. PubMed ID: 15245748 [TBL] [Abstract][Full Text] [Related]
37. The biology of nerve injury in leprosy. Scollard DM Lepr Rev; 2008 Sep; 79(3):242-53. PubMed ID: 19009974 [TBL] [Abstract][Full Text] [Related]
38. The role of free-living pathogenic amoeba in the transmission of leprosy: a proof of principle. Lahiri R; Krahenbuhl JL Lepr Rev; 2008 Dec; 79(4):401-9. PubMed ID: 19274986 [TBL] [Abstract][Full Text] [Related]
39. Mast cell and Mycobacterium leprae in experimental leprosy. Kumar R; Vaidya MC Hansenol Int; 1982 Jun; 7(1):1-7. PubMed ID: 6764919 [TBL] [Abstract][Full Text] [Related]